The mechanisms of hyperphosphatemia-induced vascular calcification

International Journal of Artificial Organs

Volumn 31, Issue 12, 2008, Pages 1002-1003

  Cozzolino, Mario ^a   Gallieni, M ^a   Brancaccio, D ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Chronic kidney disease; Phosphate; Vascular calcification

Indexed keywords

BONE; CALCIUM PHOSPHATE; HISTOLOGY;

ARTERIAL WALL; BONE METABOLISM; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; HYPERPARATHYROIDISM; INDUCING FACTORS; INORGANIC PHOSPHATES; RENAL FAILURE; SOFT TISSUE; VASCULAR CALCIFICATION;

BIOMINERALIZATION;

CALCIUM; PHOSPHATE;

ARTERIAL STIFFNESS; ARTERY CALCIFICATION; ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; BONE METABOLISM; CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; CORONARY ARTERY DISEASE; CRYSTALLIZATION; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE COURSE; EDITORIAL; HEART LEFT VENTRICLE HYPERTROPHY; HEMODIALYSIS; HUMAN; HYPERCALCEMIA; HYPERPHOSPHATEMIA; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PHOSPHATE BLOOD LEVEL; RISK ASSESSMENT; SECONDARY HYPERPARATHYROIDISM; SYSTOLIC BLOOD PRESSURE; TUNICA MEDIA; UREMIA;

EID: 60749112860     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880803101203     Document Type: Editorial

References (14)

1. Brancaccio D, Cozzolino M. The mechanism of calcium deposition in soft tissues. Contrib Nephrol 2005; 149: 279-86.
2. Braun J, Oldendorf M, Moshage W, et al. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 1996; 27: 394-401.
3. London GM. Cardiovascular calcifications in uremic patients: clinical impact on cardiovascular function. J Am Soc Nephrol 2003; 14: S305-9.
4. Schwartz U, Buzzello M, Ritz E, et al. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant 2000; 15: 218-23.
5. Cozzolino M, Dusso A, Slatopolsky E. Role of calcium x phosphate product and bone associated proteins on vascular calcification in renal failure. J Am Soc Nephrol 2001; 12: 2511-6.
6. Cozzolino M, Brancaccio D, Gallieni M, Slatopolsky E. Pathogenesis of vascular calcification in chronic kidney disease. Kidney Int 2005; 68: 429-36.
7. Goodman WG, Goldin J, Kuizon BD, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000; 342: 1478-83.
8. Jono S, McKee MD, Murry CE, et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000; 87: E10-7.
9. Kajbaf S, Veinot JP, Ha A, Zimmerman D. Comparison of surgically removed cardiac valves of patients with ESRD with those of the general population. Am J Kidney Dis 2005; 46: 86-93.
10. Cozzolino M, Brancaccio D. Hyperphosphatemia in dialysis patients: the therapeutic role of lanthanum carbonate. Int J Artif Organs 2007; 30: 293-300.
11. Ducy P, Zhang R, Geoffroy V, et al. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997; 89: 747-54.
12. Chen NX, O'Neill KD, Duan D, Moe SM. Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells. Kidney Int 2002; 62: 1724-31.
13. Moe SM, Duan D, Doehle BP, et al. Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels. Kidney Int 2006; 63: 1003-11.
14. Price PA, Caputo JM, Williamson MK. Bone origin of the serum complex of calcium, phosphate, fetuin, and matrix Gla protein: biochemical evidence for the cancellous bone-remodeling compartment. J Bone Miner Res 2002; 17: 1171-9.